46
Participants
Start Date
May 4, 2021
Primary Completion Date
March 30, 2024
Study Completion Date
December 31, 2025
Guanfacine
Patients randomized to the IV Guanfacine arm will receive intravenous guanfacine when they exhibit ICU delirium.
Placebo
Patients randomized to the placebo arm will receive intravenous normal saline when they exhibit ICU delirium.
Vanderbilt University Medical Center, Nashville
Massachusetts General Hospital
OTHER
National Institute on Aging (NIA)
NIH
Vanderbilt University Medical Center
OTHER